P3 Prostate Cancer Forum: 2024
Session 3 - Mapping the Journey: Strategies and RWE in nmCRPC

In session 3, we gained insights into nmCRPC patients in the UK, and discussed how the treatment paradigm is shifting in this patient group, as next-generation imaging becomes increasingly available and primary treatment choices are changing.
Download the summary below for the key takeaways from this meeting.
In session 4, we took a deep dive into mCRPC, the latest therapies and data and key considerations for treatment sequencing in this patient group
PP-NUB-GB-2017, January 2025